MCID: PRN032
MIFTS: 28

Paraneoplastic Cerebellar Degeneration

Categories: Cancer diseases, Immune diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Paraneoplastic Cerebellar Degeneration

MalaCards integrated aliases for Paraneoplastic Cerebellar Degeneration:

Name: Paraneoplastic Cerebellar Degeneration 52 54 71

Classifications:



External Ids:

UMLS 71 C0393534

Summaries for Paraneoplastic Cerebellar Degeneration

NIH Rare Diseases : 52 Paraneoplastic syndromes are a group of rare disorders that include paraneoplastic cerebellar degeneration (PCD). Paraneoplastic syndromes are thought to result from an abnormal immune response to an underlying (and often undetected) malignant tumor . PCD is a rare, non-metastatic complication of cancer . PCD is typically thought to be caused by antibodies generated against tumor cells . Instead of just attacking the cancer cells, the cancer-fighting antibodies also attack normal cells in the cerebellum . PCD occurs most often in individuals with the following cancers: ovarian cancer, cancer of the uterus, breast cancer, small-cell lung cancer, and Hodgkin lymphoma. Symptoms of PCD may include dizziness, loss of coordination, blurred vision, nystagmus , ataxia , and speech difficulties.

MalaCards based summary : Paraneoplastic Cerebellar Degeneration is related to cerebellar degeneration and paraneoplastic neurologic disorders, and has symptoms including cerebellar ataxia An important gene associated with Paraneoplastic Cerebellar Degeneration is CDR2 (Cerebellar Degeneration Related Protein 2). The drugs Immunologic Factors and Immunoglobulins have been mentioned in the context of this disorder. Affiliated tissues include lung, breast and cerebellum.

Wikipedia : 74 Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic syndrome associated with a broad... more...

Related Diseases for Paraneoplastic Cerebellar Degeneration

Diseases related to Paraneoplastic Cerebellar Degeneration via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 135, show less)
# Related Disease Score Top Affiliating Genes
1 cerebellar degeneration 32.7 CDR2 CDR1
2 paraneoplastic neurologic disorders 11.8
3 subacute cerebellar degeneration 11.7
4 ataxia and polyneuropathy, adult-onset 10.9
5 aceruloplasminemia 10.7
6 ovarian cancer 10.7
7 pathologic nystagmus 10.6
8 adenocarcinoma 10.6
9 paraneoplastic syndromes 10.6
10 breast cancer 10.5
11 lambert-eaton myasthenic syndrome 10.5
12 small cell carcinoma 10.5
13 small cell cancer of the lung 10.5
14 ovary adenocarcinoma 10.4
15 tremor 10.4
16 lymphoma, hodgkin, classic 10.4
17 lymphoma 10.4
18 limbic encephalitis 10.4
19 dysphagia 10.4
20 encephalitis 10.3
21 fallopian tube adenocarcinoma 10.3
22 gastric adenocarcinoma 10.3
23 autoimmune disease 10.2
24 bladder cancer 10.2
25 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.2
26 diffuse large b-cell lymphoma 10.2
27 lung oat cell carcinoma 10.2
28 b-cell lymphoma 10.2
29 hodgkin's lymphoma, lymphocytic-histiocytic predominance 10.2
30 lung cancer 10.2
31 endometrial cancer 10.2
32 squamous cell carcinoma 10.2
33 myoclonus 10.2
34 renal cell carcinoma, nonpapillary 10.1
35 myeloma, multiple 10.1
36 follicular lymphoma 10.1
37 ptosis 10.1
38 nephrotic syndrome 10.1
39 neuroendocrine carcinoma 10.1
40 fallopian tube carcinoma 10.1
41 sensory peripheral neuropathy 10.1
42 cerebellar disease 10.1
43 papillary carcinoma 10.1
44 serous cystadenocarcinoma 10.1
45 merkel cell carcinoma 10.1
46 severe combined immunodeficiency 10.1
47 combined t cell and b cell immunodeficiency 10.1
48 neuroblastoma 10.1
49 colorectal cancer 9.9
50 major affective disorder 1 9.9
51 multiple sclerosis 9.9
52 melanoma, uveal 9.9
53 mesothelioma, malignant 9.9
54 papillomatosis, confluent and reticulated 9.9
55 gaucher disease, type i 9.9
56 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
57 thymoma, familial 9.9
58 suppression of tumorigenicity 12 9.9
59 pulmonary disease, chronic obstructive 9.9
60 nasopharyngeal carcinoma 9.9
61 ewing sarcoma 9.9
62 major affective disorder 8 9.9
63 major affective disorder 9 9.9
64 lung cancer susceptibility 3 9.9
65 cholangiocarcinoma 9.9
66 helix syndrome 9.9
67 secondary progressive multiple sclerosis 9.9
68 ovarian serous carcinoma 9.9
69 ovarian clear cell carcinoma 9.9
70 marantic endocarditis 9.9
71 dermatomyositis 9.9
72 viral meningitis 9.9
73 endocarditis 9.9
74 hydrocephalus 9.9
75 horner's syndrome 9.9
76 cardiac tamponade 9.9
77 bronchopneumonia 9.9
78 polyneuropathy 9.9
79 facial paralysis 9.9
80 neuroendocrine tumor 9.9
81 pericarditis 9.9
82 gaucher's disease 9.9
83 colon adenocarcinoma 9.9
84 relapsing-remitting multiple sclerosis 9.9
85 benign mesothelioma 9.9
86 transitional cell carcinoma 9.9
87 breast ductal carcinoma 9.9
88 glioblastoma multiforme 9.9
89 myelitis 9.9
90 thymoma 9.9
91 germinoma 9.9
92 teratoma 9.9
93 bipolar disorder 9.9
94 liposarcoma 9.9
95 breast adenocarcinoma 9.9
96 pseudomyxoma peritonei 9.9
97 bladder urothelial carcinoma 9.9
98 spindle cell carcinoma 9.9
99 ganglioneuroblastoma 9.9
100 carcinosarcoma 9.9
101 gastric neuroendocrine neoplasm 9.9
102 bronchiolo-alveolar adenocarcinoma 9.9
103 intrahepatic cholangiocarcinoma 9.9
104 gastroesophageal junction adenocarcinoma 9.9
105 sleep disorder 9.9
106 mature teratoma 9.9
107 lymphoepithelioma-like carcinoma 9.9
108 peripheral nervous system disease 9.9
109 composite lymphoma 9.9
110 ovarian carcinosarcoma 9.9
111 mitochondrial metabolism disease 9.9
112 malignant pleural mesothelioma 9.9
113 peritonitis 9.9
114 vasculitis 9.9
115 neuropathy 9.9
116 in situ carcinoma 9.9
117 rem sleep behavior disorder 9.9
118 intracranial hypertension 9.9
119 mitochondrial disorders 9.9
120 autoimmune encephalitis 9.9
121 glioma 9.9
122 opsoclonus-myoclonus syndrome 9.9
123 pseudobulbar affect 9.9
124 pure autonomic failure 9.9
125 dysautonomia 9.9
126 spinocerebellar degeneration 9.9
127 thyroid carcinoma 9.9
128 acute diffuse nephritis 9.9 CDR2 CDR1
129 retinitis pigmentosa 47 9.9 CDR2 CDR1
130 retinitis pigmentosa 57 9.9 CDR2 CDR1
131 anosognosia 9.8 CDR2 CDR1
132 denture stomatitis 9.8 CDR2 CDR1
133 schuurs-hoeijmakers syndrome 9.7 CDR2 CDR1
134 cone-rod dystrophy 1 9.7 CDR2 CDR1
135 autosomal dominant non-syndromic intellectual disability 9.5 CDR2 CDR1

Graphical network of the top 20 diseases related to Paraneoplastic Cerebellar Degeneration:



Diseases related to Paraneoplastic Cerebellar Degeneration

Symptoms & Phenotypes for Paraneoplastic Cerebellar Degeneration

UMLS symptoms related to Paraneoplastic Cerebellar Degeneration:


cerebellar ataxia

Drugs & Therapeutics for Paraneoplastic Cerebellar Degeneration

Drugs for Paraneoplastic Cerebellar Degeneration (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 10, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Immunologic Factors Phase 2
2 Immunoglobulins Phase 2
3 Antibodies Phase 2
4 Rho(D) Immune Globulin Phase 2
5 Immunoglobulins, Intravenous Phase 2
6 gamma-Globulins Phase 2
7
Tacrolimus Approved, Investigational 104987-11-3 445643 439492 6473866
8
Prednisone Approved, Vet_approved 53-03-2 5865
9 Immunosuppressive Agents
10 Calcineurin Inhibitors

Interventional clinical trials:

(showing 2, show less)
# Name Status NCT ID Phase Drugs
1 Early Onset Immunotherapy by Intravenous Immunoglobulin in Well-characterized Onconeural-antibody-positive Paraneoplastic Neurological Syndromes Completed NCT02343211 Phase 2 Immunoglobulin
2 Immunotherapy of the Paraneoplastic Syndromes Completed NCT00378326 Tacrolimus

Search NIH Clinical Center for Paraneoplastic Cerebellar Degeneration

Genetic Tests for Paraneoplastic Cerebellar Degeneration

Anatomical Context for Paraneoplastic Cerebellar Degeneration

MalaCards organs/tissues related to Paraneoplastic Cerebellar Degeneration:

40
Lung, Breast, Cerebellum, T Cells, Uterus, B Cells, Brain

Publications for Paraneoplastic Cerebellar Degeneration

Articles related to Paraneoplastic Cerebellar Degeneration:

(showing 499, show less)
# Title Authors PMID Year
1
Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration. 54 61
18053582 2008
2
Induction of cytotoxic T lymphocytes specific for paraneoplastic cerebellar degeneration-associated antigen in vivo by DNA immunization. 54 61
11771954 2001
3
Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration. 54 61
11489286 2001
4
Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors. 54 61
10786675 2000
5
Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody. 54 61
10500270 1999
6
The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. 54 61
10465786 1999
7
Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. 54 61
9879687 1998
8
Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. 54 61
9527904 1998
9
Expression of messenger RNA encoding a paraneoplastic cerebellar degeneration-associated antigen in the rat hippocampus. 54 61
8545049 1995
10
Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. 54 61
7788964 1995
11
Combined Cerebellar and Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy. 61
31970005 2020
12
Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association. 61
31161534 2019
13
Non-small cell lung cancer associated with late-onset Lambert-Eaton myasthenic syndrome and paraneoplastic cerebellar degeneration. 61
31735997 2019
14
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature. 61
31463826 2019
15
Cerebellar Hypermetabolism in a Case of Paraneoplastic Cerebellar Syndrome With the Primary Lymphoepithelial Carcinoma in Tonsil. 61
31162262 2019
16
Rare case of paraneoplastic cerebellar degeneration secondary to high-grade serous carcinoma of tubo-ovarian origin. 61
31466977 2019
17
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration. 61
31148214 2019
18
GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome. 61
31236596 2019
19
Cerebellar Ataxia With Extreme Photophobia Associated With Anti-SOX1 Antibodies. 61
31244974 2019
20
[Paraneoplastic cerebellar degeneration and primary fallopian cancer]. 61
31239210 2019
21
Revisiting the Clinical Phenomenology of "Cerebellar Tremor": Beyond the Intention Tremor. 61
30565088 2019
22
A quaint masquerader of breast cancer: Paraneoplastic cerebellar degeneration. 61
31347580 2019
23
TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration. 61
30350014 2019
24
IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration. 61
30944244 2019
25
'A Story Unheard': anti-Ta associated paraneoplastic cerebellar degeneration in a female. 61
31044049 2019
26
Transient Diffusion-weighted Imaging Hyperintensity of the Cerebellar Cortex in Paraneoplastic Cerebellar Degeneration. 61
30210124 2019
27
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity. 61
29679372 2019
28
[Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases]. 61
30718446 2019
29
The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders. 61
30445363 2019
30
Long-Standing evolution of paraneoplastic cerebellar degeneration in a diffuse large B-cell lymphoma. 61
30476652 2019
31
Paraneoplastic cerebellar degeneration as initial presentation of renal cell carcinoma. 61
31333854 2019
32
Variant Guillain-Barré syndrome in a patient with Hodgkin lymphoma: AMSAN. 61
30872931 2018
33
Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review. 61
30607127 2018
34
Pearls & Oy-sters: Windmill nystagmus in paraneoplastic cerebellar degeneration. 61
30397048 2018
35
[A Case of Rectal Colon Cancer with Paraneoplastic Cerebellar Degeneration]. 61
30382061 2018
36
Paraneoplastic Cerebellar Degeneration Associated With Ovarian Adenocarcinoma: A Case Report and Review of Literature. 61
30532364 2018
37
Time Is Cerebellum. 61
29460203 2018
38
Paraneoplastic cerebellar degeneration associated with breast cancer: A case report and review of the literature. 61
30101014 2018
39
Paraneoplastic cerebellar degeneration as a manifestation of metastatic recurrent carcinoma breast: rare scenario. 61
30150330 2018
40
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies. 61
29899393 2018
41
Paraneoplastic cerebellar degeneration with bilateral facial palsy: a rare primary presentation of breast cancer. 61
29930189 2018
42
Paraneoplastic cerebellar degeneration in a patient with anaplastic non-Hodgkin's lymphoma. 61
29909387 2018
43
[Paraneoplastic Syndromes in Ophthalmology (French version of the article)]. 61
29891101 2018
44
Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report. 61
29901574 2018
45
Paraneoplastic syndrome associate with solitary fibrous tumor of pleura. 61
29697083 2018
46
Paraneoplastic syndromes in ophthalmology. 61
29784239 2018
47
Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer. 61
29844866 2018
48
[Paraneoplastic cerebellar degeneration (PCD) - an interdisciplinary challenge in neurology, oncology and palliative care]. 61
29411193 2018
49
[Cerebellar Ataxia and Autoantibodies]. 61
29632285 2018
50
[P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome]. 61
29632282 2018
51
Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration Manifesting as Acute Cerebellitis with Posterior Cranial Fossa Hypertension. 61
29378343 2018
52
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. 61
29299667 2018
53
Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy. 61
30225435 2018
54
Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies. 61
29306402 2018
55
[A retrospective study of the effects of 3,4-diaminopyridine treatment in Lambert-Eaton myasthenic syndrome]. 61
29386498 2018
56
Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx. 61
29093415 2018
57
Paraneoplastic Cerebellar Degeneration Associated with Pelvic Liposarcoma: A Rare Case Report. 61
28092914 2018
58
Thymic Carcinoma Associated with Cerebellar Degeneration. 61
30756016 2018
59
The neuropathology of the adult cerebellum. 61
29903436 2018
60
Anti-ZIC4 associated paraneoplastic cerebellar degeneration in a patient with both diffuse large B-cell lymphoma and incidental smoldering multiple myeloma. 61
29249374 2018
61
Intensive Combination Immunotherapy and Neuroinflammation Resolution in a Child With Anti-PCA-1 (Yo) Paraneoplastic Syndrome and 2 Malignancies. 61
30288393 2018
62
Paraneoplastic autoimmune movement disorders. 61
29097081 2017
63
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies. 61
28710511 2017
64
Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies. 61
28006860 2017
65
Rehabilitation for a patient with anti-Yo antibody-positive paraneoplastic cerebellar degeneration caused by breast cancer: A case report and literature review. 61
29095299 2017
66
T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy. 61
29093272 2017
67
A Rare Clinical Entity in Bladder Cancer: Paraneoplastic Cerebellar Degeneration. 61
28506560 2017
68
Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: A case report. 61
28796031 2017
69
The Complex Diagnostic Challenge in Children With Non-Central Nervous System Cancer and Cerebellar Mutism. 61
28497710 2017
70
Paraneoplastic cerebellar degeneration secondary to ovarian carcinosarcoma: a cerebellar conundrum. 61
28790096 2017
71
Erratum to: Hodgkin's lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature. 61
28447149 2017
72
Paraneoplastic cerebellar degeneration in a patient with a primary fallopian tube adenocarcinoma. A case report and brief review. 61
28386581 2017
73
Hodgkin's lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature. 61
27796550 2017
74
Adult Onset Sporadic Cerebellar Ataxia in Singapore: Diagnostic Outcomes of Paraneoplastic Antibody Testing and Early Clinical Features of Paraneoplastic Cerebellar Degeneration. 61
28417137 2017
75
Restoring Balance: Paraneoplastic Cerebellar Degeneration. 61
27816447 2017
76
Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies. 61
28203616 2017
77
Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma. 61
27816258 2017
78
Anti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer. 61
28377827 2017
79
[Paraneoplastic cerebellar degeneration associated with anti-Ma2 antibodies]. 61
27650210 2016
80
Paraneoplastic Cerebellar Degeneration-A Rare Presentation of Ovarian Malignancy. 61
27803545 2016
81
Autoimmune neurological syndromes associated limbic encephalitis and paraneoplastic cerebellar degeneration. 61
27592059 2016
82
Anti-Ri antibody-mediated paraneoplastic cerebellar degeneration: A rare, treatable yet poorly recognized entity. 61
27625249 2016
83
Voltage-Gated P/Q-Type Calcium Channel Antibodies Associated With Cerebellar Degeneration. 61
27436538 2016
84
Cerebellar Degeneration as a Rare Paraneoplastic Syndrome in a Child With Hodgkin Lymphoma. 61
26599987 2016
85
Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review. 61
27606347 2016
86
A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy. 61
27356731 2016
87
Paraneoplastic cerebellar degeneration as a marker of endometrial cancer recurrence. 61
27194676 2016
88
Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes. 61
27007485 2016
89
An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: A case report and literature review. 61
27209351 2016
90
Paraneoplastic cerebellar degeneration and endometrial cancer: a rare occurrence. 61
27020505 2016
91
Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias. 61
25823827 2016
92
Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration. 61
26271804 2016
93
Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphoma. 61
26542148 2016
94
Rapid Eye Movement Sleep Behavior Disorder in Paraneoplastic Cerebellar Degeneration: Improvement with Immunotherapy. 61
26414894 2016
95
Paraneoplastic cerebellar degeneration associated with small cell neuroendocrine mediastinal carcinoma. 61
26026691 2015
96
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer. 61
26694863 2015
97
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature. 61
26582328 2015
98
[Clinical features and treatment of paraneoplastic neurological syndrome associated with small cell lung cancer]. 61
26814083 2015
99
A Rare Case of Ovarian Cancer Presenting with Paraneoplastic Cerebellar Degeneration and Limbic Encephalitis. 61
26415811 2015
100
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases. 61
26345279 2015
101
Plasticity-related gene 5: A novel surface autoantigen in paraneoplastic cerebellar degeneration. 61
26445730 2015
102
[Paraneoplastic cerebellar degeneration (PCD)]. 61
26480789 2015
103
Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries. 61
25966874 2015
104
Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies. 61
26099072 2015
105
Paraneoplastic cerebellar degeneration with anti-CV2/CRMP5 antibodies and prostate adenocarcinoma. 61
25686614 2015
106
Acquired Hypertrichosis Lanuginosa: Typical Presentation and Unusual Association. 61
26161711 2015
107
Paraneoplastic cerebellar degeneration in a patient with ovarian cancer. 61
26166348 2015
108
Cystatin C is differentially involved in multiple system atrophy phenotypes. 61
24606172 2015
109
Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration. 61
25745634 2015
110
Paraneoplastic cerebellar ataxia and the paraneoplastic syndromes. 61
25829659 2015
111
Voltage gated calcium channel antibody-related neurological diseases. 61
25789302 2015
112
Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma. 61
25443085 2015
113
Guidelines for treatment of immune-mediated cerebellar ataxias. 61
26561527 2015
114
Paraneoplastic syndromes in olfactory neuroblastoma. 61
26199564 2015
115
Surgical diagnosis of stage I fallopian tube cancer in anti-Yo antibody paraneoplastic cerebellar degeneration. 61
24960213 2015
116
Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject. 61
26366356 2015
117
Paraneoplastic neurological syndromes associated with ovarian tumors. 61
24965744 2015
118
Cerebellar hypermetabolism on ¹⁸F-FDG PET/CT with normal MRI in a case of paraneoplastic cerebellar degeneration with negative antibodies. 61
25001850 2015
119
Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. 61
25885452 2015
120
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. 61
25341622 2014
121
Inpatient rehabilitation performance of patients with paraneoplastic cerebellar degeneration. 61
25051460 2014
122
Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary. 61
25432905 2014
123
[Sudden death occurring after anti-Hu associated paraneoplastic cerebellar degeneration and dysautonomia revealing a small cell lung carcinoma]. 61
24411475 2014
124
Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. 61
25023997 2014
125
Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma. 61
24935874 2014
126
Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinoma. 61
25340069 2014
127
Carbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degeneration. 61
24446689 2014
128
Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-yo antibody mediated paraneoplastic cerebellar degeneration. 61
25221413 2014
129
Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. 61
24705493 2014
130
Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience. 61
24471811 2014
131
Paraneoplastic cerebellar degeneration as the first evidence of malignancy: a case report. 61
24689522 2014
132
Rapid, severe neurological impairment associated with paraneoplastic cerebellar degeneration and anti-Yo antibodies. 61
22981373 2014
133
Diffuse large B-cell lymphoma of stomach presenting with paraneoplastic cerebellar degeneration syndrome. 61
24717988 2014
134
Hodgkin lymphoma-associated paraneoplastic cerebellar degeneration on FDG-PET/CT. 61
24460525 2014
135
Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma. 61
24148073 2014
136
Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report. 61
25360186 2014
137
Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma. 61
24035275 2013
138
Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type. 61
24018129 2013
139
Gastric diffuse large B cell lymphoma presenting as paraneoplastic cerebellar degeneration: case report and review of literature. 61
24207096 2013
140
[Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report]. 61
24200618 2013
141
[Paraneoplastic cerebellar degeneration as the presenting manifestation of breast carcinoma: a case report]. 61
24367813 2013
142
Paraneoplastic cerebellar degeneration associated with squamous cell carcinoma of the lung. 61
23790624 2013
143
MR spectroscopy in paraneoplastic cerebellar degeneration. 61
23433908 2013
144
Paraneoplastic cerebellar degeneration associated with lymphoepithelial carcinoma of the tonsil. 61
24134642 2013
145
Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review. 61
23585287 2013
146
Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. 61
23726906 2013
147
Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinoma. 61
23531419 2013
148
Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma. 61
23475537 2013
149
Treatment of paraneoplastic cerebellar degeneration. 61
23315179 2013
150
Protein kinase Cγ antibodies and paraneoplastic cerebellar degeneration. 61
23273977 2013
151
Paraneoplastic Cerebellar Degeneration as Initial Presentation of Papillary Carcinoma of the Fallopian Tube: Evaluation and Usefulness of (18)F-FDG PET-CT. Case Report and Literature Review. 61
24895509 2013
152
[Paraneoplastic cerebellar degeneration associated with ganglioneuroblastoma in a boy]. 61
23498769 2013
153
Paraneoplastic cerebellar degeneration associated with ovarian cancer. 61
23420048 2013
154
Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. 61
23536908 2013
155
Neurological paraneoplastic syndromes in lung cancer patients. 61
22836651 2013
156
[Synchronous appearance and improvement with anticancer chemotherapy of paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome complicated with small cell lung cancer]. 61
23470889 2013
157
CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration. 61
23823982 2013
158
Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung. 61
24167748 2013
159
Superior cerebellar hyperintense sign on FLAIR-weighted magnetic resonance imaging in paraneoplastic cerebellar degeneration. 61
23295431 2012
160
Diagnostic Approach to a Patient With Paraneoplastic Neurological Syndrome. 61
29147315 2012
161
Acute ataxia due to anti-Yo antibody paraneoplastic cerebellar degeneration 4 months prior to diagnosis of uterine carcinoma. 61
22426676 2012
162
Paraneoplastic cerebellar degeneration associated with thymic germinoma. 61
22795387 2012
163
Paraneoplastic cerebellar degeneration in Hodgkin's lymphoma. 61
22919195 2012
164
Anti-Yo and anti-glutamic acid decarboxylase antibodies presenting in carcinoma of the uterus with paraneoplastic cerebellar degeneration: a case report. 61
22691265 2012
165
Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. 61
22447725 2012
166
Rituximab as potential therapy for paraneoplastic cerebellar degeneration in pediatric Hodgkin disease. 61
22532986 2012
167
Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration. 61
22351748 2012
168
The role of breast MRI in the investigation of anti-Yo positive paraneoplastic cerebellar degeneration. 61
22605818 2012
169
Magnetic resonance and nuclear medicine imaging in ataxias. 61
21827882 2012
170
Immune-mediated acquired ataxias. 61
21827889 2012
171
A case of follicular lymphoma associated with paraneoplastic cerebellar degeneration. 61
22687848 2012
172
Paraneoplastic cerebellar degeneration. 61
21827891 2012
173
Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status. 61
22934121 2012
174
VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo. 61
21678073 2011
175
[The pathophysiology and treatment of autoimmune neuromuscular junction diseases]. 61
22277398 2011
176
Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. 61
21670387 2011
177
Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature. 61
22028093 2011
178
Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration. 61
21762925 2011
179
Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor. 61
21825246 2011
180
Current approaches to the treatment of paraneoplastic encephalitis. 61
21765874 2011
181
[Lambert-Eaton myasthenic syndrome]. 61
21747145 2011
182
[A case of small cell lung cancer that presented with paraneoplastic syndrome]. 61
21842689 2011
183
FDG-PET hypermetabolism in paraneoplastic cerebellar degeneration. 61
21748944 2011
184
Paraneoplastic cerebellar degeneration and anti-Yo antibodies. 61
21353726 2011
185
Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration. 61
21174114 2011
186
Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis. 61
21148018 2011
187
Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer. 61
20392978 2011
188
Spectrum of paraneoplastic disease associated with lymphoma. 61
21339498 2011
189
CDR2 antigen and Yo antibodies. 61
21080165 2011
190
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. 61
20880069 2011
191
Hodgkin's Lymphoma: A Review of Neurologic Complications. 61
20975772 2011
192
A rare case of breast carcinoma presenting with paraneoplastic cerebellar degeneration. 61
24945843 2010
193
Bipolar disorder associated with paraneoplastic cerebellar degeneration: a case report. 61
21057423 2010
194
Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review. 61
20460982 2010
195
Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. 61
20838245 2010
196
Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease? 61
20457964 2010
197
Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate. 61
20089262 2010
198
Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma. 61
19798470 2010
199
The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells. 61
20383333 2010
200
[Paraneoplastic cerebellar degeneration]. 61
20420175 2010
201
Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. 61
19943166 2010
202
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 61
19806316 2010
203
Paraneoplastic cerebellar degeneration mimicking acute post-infectious cerebellitis. 61
19727999 2009
204
Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome. 61
20156748 2009
205
Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review. 61
19779120 2009
206
SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. 61
19667272 2009
207
[Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer]. 61
19803409 2009
208
Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions. 61
19544138 2009
209
Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. 61
19509467 2009
210
Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. 61
19486326 2009
211
Ovarian cancer and late onset paraneoplastic cerebellar degeneration. 61
18987868 2009
212
Morphology and immuno-distribution of the histamine H4 receptor and histamine--releasing factor in choroid plexus of patients with paraneoplastic cerebellar degeneration. 61
19271148 2009
213
CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration. 61
19217169 2009
214
Calbindin positive Purkinje cells in the pathology of human cerebellum occurring at the time of its development. 61
20054781 2009
215
Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study. 61
18701208 2008
216
[Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis]. 61
19110759 2008
217
Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation. 61
18217973 2008
218
Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. 61
18687732 2008
219
ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer. 61
18639938 2008
220
Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration. 61
18632117 2008
221
Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review. 61
18540952 2008
222
[Renal cell carcinoma presenting as paraneoplastic neurological dysfunction]. 61
18655350 2008
223
Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. 61
18297363 2008
224
Paraneoplastic syndromes of the CNS. 61
18339348 2008
225
Paraneoplastic cerebellar degeneration as a presentation of breast cancer - a case report and review of the literature. 61
18426566 2008
226
[A case of paraneoplastic cerebellar degeneration associated with small cell lung cancer showing marked response to intravenous immunoglobulin]. 61
18516998 2008
227
Small cell lung cancer. 61
18316005 2008
228
A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers. 61
18257818 2008
229
Successful treatment of paraneoplastic cerebellar degeneration with Rituximab. 61
17924058 2008
230
Unusual MRI abnormalities in anti-Yo positive "pure" paraneoplastic cerebellar degeneration. 61
17994310 2008
231
Papillary serous carcinomas of the uterine cervix and paraneoplastic cerebellar degeneration: a report of two cases. 61
18941954 2008
232
[From psychiatric symptoms to paraneoplastic syndrome]. 61
18785107 2008
233
A T-cell receptor associated with naturally occurring human tumor immunity. 61
18045792 2007
234
[Synchronic paraneoplastic cerebellar degeneration and retinopathy]. 61
17988621 2007
235
[P/Q-type voltage-dependent calcium channels in neurological disease]. 61
17573560 2007
236
Paraneoplastic syndrome in vaginal melanoma: a case report and review of the literature. 61
17309666 2007
237
Acute onset paraneoplastic cerebellar degeneration. 61
17638062 2007
238
Paraneoplastic cerebellar degeneration and anti-Yo antibodies in a man with prostatic adenocarcinoma. 61
17189300 2007
239
Autoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma. 61
17613783 2007
240
Endometrial carcinoma first presenting as paraneoplastic cerebellar degeneration. 61
17428523 2007
241
Ovarian cancer: PCD and brain metastases. 61
17847951 2007
242
Marantic endocarditis (NBTE) with systemic emboli and paraneoplastic cerebellar degeneration: uncommon presentation of ovarian cancer. 61
17205388 2007
243
A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET. 61
17368524 2007
244
Seek and ye shall find: Hodgkin's lymphoma presenting as paraneoplastic cerebellar degeneration. 61
17460745 2007
245
[Paraneoplasic cerebellar degeneration as a presentation of breast cancer recurrence]. 61
17590135 2007
246
Progressive ataxic gait disorder. 61
17161290 2007
247
[85-years-old patient with paraneoplastic polyneuropathy]. 61
17726875 2007
248
Parkinsonism & related disorders. Ataxias. 61
18267270 2007
249
Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody. 61
16773214 2007
250
Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction. 61
17785986 2007
251
Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. 61
16801349 2006
252
Frontal executive impairment associated with paraneoplastic cerebellar degeneration: a case study. 61
17182399 2006
253
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET. 61
17011583 2006
254
Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease. 61
17065013 2006
255
Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. 61
16834698 2006
256
Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma. 61
16929086 2006
257
Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung. 61
16644410 2006
258
Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study. 61
16543544 2006
259
Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration. 61
16543536 2006
260
Clinical insights into paraneoplastic cerebellar degeneration. 61
16543537 2006
261
Paraneoplastic cerebellar degeneration: new insights into imaging and immunology. 61
16543516 2006
262
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique. 61
16542365 2006
263
[Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report]. 61
16619840 2006
264
A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody. 61
16556143 2006
265
Paraneoplastic cerebellar degeneration in a woman with ovarian cancer. 61
16462852 2006
266
Detection of anti-brain serum antibodies using a semi-quantitative immunohistological method. 61
16413571 2006
267
[A case of small cell carcinoma of the lung associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome]. 61
16482925 2006
268
Paraneoplastic cerebellar degeneration in olfactory neuroepithelioma. 61
16361612 2006
269
Autopsy findings in the nervous system and ovarian tumour of two patients with paraneoplastic cerebellar degeneration. 61
16637935 2006
270
Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma. 61
16126258 2005
271
A rare case of paraneoplastic cerebellar degeneration discovered by whole-body F-18 FDG PET. 61
16166852 2005
272
[Ataxias. Diagnostic procedure and treatment]. 61
16175415 2005
273
Proteasome antibodies in paraneoplastic cerebellar degeneration. 61
15964637 2005
274
Speech and language findings associated with paraneoplastic cerebellar degeneration. 61
16229671 2005
275
Gynaecology meets neurology: paraneoplastic cerebellar degeneration. 61
16029316 2005
276
P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer. 61
15904978 2005
277
Induction of humoral responses specific for paraneoplastic cerebellar degeneration-associated antigen by whole recombinant yeast immunization. 61
15848042 2005
278
Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration. 61
15729526 2005
279
Gynaecology meets neurology: paraneoplastic cerebellar degeneration. 61
15730373 2005
280
Gene expression profile following stable expression of the cellular prion protein. 61
15672681 2004
281
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. 61
15377687 2004
282
Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. 61
15389893 2004
283
[Cerebellar degeneration associated with anti-Tr antibodies without Hodgkin's disease. Four years follow-up]. 61
15470588 2004
284
Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum. 61
15342206 2004
285
Paraneoplastic cerebellar degeneration (PCD) associated with squamous cell carcinoma of the lung. 61
15335190 2004
286
[Imaging neurological complications from bronchogenic carcinoma]. 61
15205650 2004
287
Heterogeneous expression of CD59 on human Purkinje cells. 61
15147772 2004
288
An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies. 61
15081253 2004
289
Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity. 61
15056460 2004
290
[Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration]. 61
15125396 2004
291
Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer. 61
14594156 2003
292
Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma. 61
14600654 2003
293
Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration. 61
12965268 2003
294
Paraneoplastic cerebellar degeneration and antibodies to P/Q-type calcium channels. 61
12891689 2003
295
Paraneoplastic cerebellar degeneration with ovarian endometroid carcinoma. 61
12790851 2003
296
Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. 61
12764061 2003
297
Acute onset paraneoplastic cerebellar degeneration in a patient with small cell lung cancer. 61
14571014 2003
298
Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. 61
12825823 2003
299
Rehabilitation treatment options for a patient with paraneoplastic cerebellar degeneration. 61
12544763 2003
300
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. 61
12552036 2003
301
Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. 61
12509844 2003
302
The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction. 61
12509857 2003
303
[Paraneoplastic cerebellar degeneration as initial presentation of a pancreatic small-cell carcinoma]. 61
12497294 2002
304
Pathogenesis and treatment of paraneoplastic neurologic syndrome. 61
19810923 2002
305
Distant effects of cancer on the nervous system. 61
12469930 2002
306
[Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma]. 61
12376889 2002
307
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. 61
12221175 2002
308
Paraneoplastic cerebellar degeneration and nephrotic syndrome preceding Hodgkin's disease: case report and review of the literature. 61
12144540 2002
309
Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X. 61
11988016 2002
310
Cancer-associated neuromusculoskeletal syndromes. Recognizing the rheumatic-neoplastic connection. 61
11985137 2002
311
[A study on pathomechanisms of paraneoplastic neurological syndrome]. 61
12235823 2001
312
Suppression of the transcriptional activity and DNA binding of nuclear factor-kappa B by a paraneoplastic cerebellar degeneration-associated antigen. 61
11525795 2001
313
Paraneoplastic cerebellar degeneration: an unusual presentation of breast carcinoma. 61
11520098 2001
314
Paraneoplastic cerebellar degeneration as the first manifestation of cancer. 61
11445049 2001
315
Are transfectant cells essential for measuring cytotoxic T cells in paraneoplastic cerebellar degeneration? 61
11357966 2001
316
Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. 61
11311295 2001
317
Paraneoplastic cerebellar degeneration heralding fallopian tube adenocarcinoma. 61
11328418 2001
318
Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration. 61
11240040 2001
319
Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. 61
11220746 2001
320
Paraneoplastic syndromes associated with anti-Hu antibodies. 61
11344832 2001
321
Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature. 61
11824891 2001
322
[A case of paraneoplastic cerebellar degeneration with resting tremor]. 61
11433763 2001
323
Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration. 61
11136578 2001
324
Paraneoplastic cerebellar degeneration: neurological symptoms pointing to occult ovarian cancer. 61
11586046 2001
325
[A case of small cell lung cancer with paraneoplastic cerebellar degeneration and anti-voltage-gated calcium channel antibody]. 61
11296385 2001
326
Morphological Purkinje cell changes in spinocerebellar ataxia type 6. 61
10985694 2000
327
Presumed immune-mediated cerebellar granuloprival degeneration in the Coton de Tuléar breed. 61
11024542 2000
328
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. 61
10980743 2000
329
cdr2-specific CTLs are detected in the blood of all patients with paraneoplastic cerebellar degeneration analyzed. 61
10939585 2000
330
What is the role of activated Th1 cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration? 61
10939586 2000
331
[Pathology of paraneoplastic syndromes. Review]. 61
10974747 2000
332
Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report. 61
10857534 2000
333
Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach. 61
10826224 2000
334
Paraneoplastic cerebellar degeneration and Horner syndrome: association of two uncommon findings in a child with Hodgkin disease. 61
10779031 2000
335
Paraneoplastic cerebellar degeneration in pediatric Hodgkin disease. 61
10774996 2000
336
[Paraneoplastic cerebellar degeneration]. 61
11269190 2000
337
[Paraneoplastic cerebellar degeneration]. 61
11031963 2000
338
Cytotoxic T cells in paraneoplastic cerebellar degeneration. 61
10632094 2000
339
Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. 61
10632096 2000
340
Malignant gastric carcinoid and paraneoplastic cerebellar degeneration. 61
10636557 1999
341
[Case of small cell carcinoma of the lung complicated with paraneoplastic cerebellar degeneration (PCD)]. 61
10630007 1999
342
[Small cell lung cancer associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome]. 61
10707541 1999
343
Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature. 61
10502450 1999
344
Positive response to therapy in a patient with a seropositive paraneoplastic cerebellar degeneration and an endometrioid carcinoma of the vesicovaginal septum. 61
10577031 1999
345
[A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody]. 61
10502981 1999
346
Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. 61
10360776 1999
347
Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degeneration. 61
10329056 1999
348
[Subacute paraneoplastic cerebellar degeneration preceding cerebellar metastasis of ovarian origin. Two rare complications of ovarian cancer]. 61
10379351 1999
349
Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. 61
10367699 1999
350
[A case of paraneoplastic cerebellar degeneration associated with small cell lung cancer]. 61
10214046 1999
351
Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome. 61
9987712 1999
352
P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. 61
9883867 1999
353
The pathophysiology of paraneoplastic neurological syndromes. 61
10021905 1998
354
A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease. 61
9858108 1998
355
Tumor-specific killer cells in paraneoplastic cerebellar degeneration. 61
9809559 1998
356
Endometroid adenocarcinoma of the ovary with a paraneoplastic syndrome. 61
9894386 1998
357
[A 64-year-old woman with progressive gait disturbance and dementia for one year]. 61
9789311 1998
358
Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system. 61
9678507 1998
359
PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. 61
9637778 1998
360
[Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma]. 61
9658519 1998
361
[Paraneoplastic cerebellar degeneration with asymmetrical pan-cerebellar syndrome]. 61
9658484 1998
362
Detection of primary tumor in paraneoplastic cerebellar degeneration by FDG-PET. 61
9585368 1998
363
Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. 61
9595993 1998
364
[Paraneoplastic cerebellar degeneration in Hodgkin's disease]. 61
9589023 1998
365
[Subacute paraneoplastic cerebellar degeneration in a patient with renal adenocarcinoma]. 61
9633217 1998
366
A patient with breast cancer and paraneoplastic cerebellar syndrome associated with anti-Purkinje cell antibodies: response to CMF chemotherapy. 61
9704186 1998
367
Case 21-1997: Paraneoplastic cerebellar degeneration and Hodgkin's disease. 61
9424575 1998
368
Antineuronal antibody-associated paraneoplastic neuropathy in Hodgkin's disease. 61
10210821 1998
369
Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer. 61
9517809 1998
370
Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. 61
9460712 1997
371
Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration. 61
9305368 1997
372
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. 61
9278623 1997
373
[Paraneoplastic cerebellar degeneration. A case report]. 61
9340852 1997
374
[Uncoupling of cerebellar blood flow and metabolism in paraneoplastic cerebellar degeneration: report of a case]. 61
9366181 1997
375
Paraneoplastic cerebellar degeneration. Case report and literature review. 61
9183238 1997
376
Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. 61
9119979 1997
377
Normalization of the tumor marker CA-125 after oophorectomy in a patient with paraneoplastic cerebellar degeneration without detectable cancer. 61
9103409 1997
378
A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. 61
9006982 1997
379
Paraneoplastic syndromes affecting the central nervous system. 61
9046952 1997
380
[A case of primary adenocarcinoma of the fallopian tube complicated with paraneoplastic cerebellar degeneration]. 61
8940699 1996
381
Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report. 61
8918408 1996
382
HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody. 61
8757056 1996
383
Subacute pancerebellar syndrome associated with systemic lupus erythematosus. 61
8836590 1996
384
Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin. 61
8628511 1996
385
[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]. 61
8682288 1996
386
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. 61
8774401 1996
387
[Small-cell carcinoma of the lung with paraneoplastic cerebellar degeneration]. 61
8778484 1996
388
[Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody]. 61
8767221 1996
389
Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. 61
8740233 1996
390
[61-year-old patient with rapidly progressive cerebellar symptoms]. 61
8584543 1995
391
Anti-Yo positive paraneoplastic cerebellar degeneration: a report of three cases and review of the literature. 61
18638835 1995
392
Paraneoplastic cerebellar degeneration in a patient with chemotherapy-responsive ovarian cancer. 61
11578511 1995
393
Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. 61
7639633 1995
394
[Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer]. 61
8777801 1995
395
Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. 61
7642741 1995
396
Paraneoplastic cerebellar degeneration: a rare presentation of Hodgkin's disease. 61
8536430 1995
397
Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man. 61
7783900 1995
398
[Pure cerebellar syndrome associated with anti-Hu antibodies]. 61
7481393 1995
399
Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. 61
8968221 1995
400
[Antineuronal autoantibody to a 40-kDa protein in a patient with cerebellar ataxia and breast cancer]. 61
7614751 1995
401
Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. 61
7788981 1995
402
Anti-tumour therapy in paraneoplastic neurological disease. 61
7788965 1995
403
Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites. 61
7540522 1995
404
Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration. 61
7876871 1995
405
[Paraneoplastic cerebellar degeneration]. 61
7669411 1995
406
Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. 61
7610765 1995
407
Paraneoplastic cerebellar degeneration in association with Hodgkin's disease: a report of two cases. 61
8610480 1995
408
Paraneoplastic cerebellar disorders. 61
7816446 1995
409
HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody. 61
7842305 1994
410
Paraneoplastic cerebellar degeneration: a rare presentation of Hodgkin's disease. 61
7537642 1994
411
Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. 61
7707074 1994
412
[Paraneoplastic cerebellar degeneration]. 61
7996701 1994
413
[Target antigens in neuroimmunological diseases]. 61
7996680 1994
414
Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration. 61
8198465 1994
415
Antineuronal antibody in Sjögren's syndrome masquerading as paraneoplastic cerebellar degeneration. 61
7907742 1994
416
[Value of the detection of anti-nervous system autoantibodies in neurologic paraneoplastic syndromes]. 61
8059119 1994
417
[The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein]. 61
8136199 1994
418
Autoantibodies in neurological paraneoplastic diseases. 61
7533934 1994
419
[Autoimmune paraneoplastic cerebellar degeneration]. 61
7801040 1994
420
[Paraneoplastic cerebellar degeneration]. 61
7863150 1994
421
[Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration]. 61
8174327 1993
422
Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. 61
8270943 1993
423
Serum antibodies to Purkinje cells and dorsal root ganglia neurons in sensory neuronopathy without malignancy. 61
8250535 1993
424
Seronegative, non-neoplastic acute cerebellar degeneration. 61
8351020 1993
425
Neurologic paraneoplastic syndromes with neurotologic manifestations. 61
8341101 1993
426
Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon. 61
8509793 1993
427
Paraneoplastic cerebellar degeneration. 61
8334587 1993
428
[A case of carcinoma of the uterine cervix accompanied with paraneoplastic cerebellar degeneration]. 61
8509674 1993
429
Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins. 61
8489208 1993
430
A case report of neurologic improvement following treatment of paraneoplastic cerebellar degeneration. 61
8469248 1993
431
Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. 61
8429313 1993
432
Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells. 61
8213077 1993
433
Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration. 61
8506746 1993
434
Paraneoplastic cerebellar degeneration: successful early detection and treatment of cancer through characterization of the anti-Purkinje cell antibody. 61
1300168 1992
435
[Subacute paraneoplastic cerebellar degeneration in microcytic carcinoma of the lung. Presentation of 2 cases]. 61
1336085 1992
436
[Autoimmune paraneoplastic neurological syndromes]. 61
1448641 1992
437
Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. 61
1407577 1992
438
Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. 61
1407576 1992
439
Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. 61
1407575 1992
440
In situ mapping of the gene coding for a leucine zipper DNA binding protein (CDR62) to 16p12-16p13.1. 61
1505970 1992
441
Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. 61
1312683 1992
442
Update of autoantibodies in neurologic disease. 61
1563241 1992
443
[A case of paraneoplastic cerebellar degeneration--success in early detection of cancer by anti-Purkinje cell antibody]. 61
1628454 1992
444
Paraneoplastic syndrome manifesting as chronic cerebellar ataxia in a child with Hodgkin disease. 61
1735828 1992
445
The expression of a cerebellar degeneration-associated neural antigen in human tumor line cells. 61
1736166 1992
446
Cerebellar granular layer degeneration in small cell lung cancer: paraneoplastic cerebellopathy or artifact? 61
1338476 1992
447
Clinical and pathological advances on central nervous system paraneoplastic syndromes. 61
1448670 1992
448
Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. 61
1779243 1991
449
Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. 61
1763903 1991
450
Multi-joint reaching movements and eye-hand tracking in cerebellar incoordination: investigation of a patient with complete loss of Purkinje cells. 61
1782614 1991
451
Breast cancer and paraneoplastic cerebellar degeneration. 61
1913530 1991
452
Antibody to a zinc finger protein in a patient with paraneoplastic cerebellar degeneration. 61
1712585 1991
453
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. 61
2014264 1991
454
A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. 61
1997480 1991
455
[Autoimmunity and paraneoplastic neurologic syndromes]. 61
1962063 1991
456
General assay for phosphoproteins in cerebrospinal fluid: a candidate marker for paraneoplastic cerebellar degeneration. 61
2285268 1990
457
Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. 61
2255217 1990
458
Internalization of plasma proteins by cerebellar Purkinje cells. 61
1708409 1990
459
Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. 61
2260856 1990
460
Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. 61
2232897 1990
461
[An autopsied case of idiopathic late cortical cerebellar atrophy--comparison with other cortical cerebellar atrophy]. 61
2085923 1990
462
Paraneoplastic cerebellar degeneration associated with multiple myeloma--3.4 years follow up. 61
2213116 1990
463
Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. 61
2356009 1990
464
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. 61
2348838 1990
465
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. 61
2326268 1990
466
Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms. 61
2685657 1989
467
Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration. 61
2818258 1989
468
Paraneoplastic opsoclonus: a neuropathologic study of two cases. 61
2559825 1989
469
Anti-neuronal autoantibodies and neurological paraneoplastic syndromes. 61
2675816 1989
470
Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. 61
2649898 1989
471
Paraneoplastic cerebellar degeneration due to Hodgkin's disease. 61
2660417 1989
472
Paraneoplastic subacute cerebellar degeneration in Hodgkin's disease. Report of three cases and review of the literature. 61
2555094 1989
473
Ovarian carcinoma and paraneoplastic cerebellar degeneration. 61
3186102 1988
474
Paraneoplastic cerebellar degeneration: clinical-immunological correlations. 61
3239956 1988
475
Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. 61
3227806 1988
476
Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. 61
3045692 1988
477
Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. 61
3049946 1988
478
A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. 61
3290700 1988
479
The metabolic anatomy of paraneoplastic cerebellar degeneration. 61
3261571 1988
480
Cerebellar dysfunction in patients with bronchogenic carcinoma: clinical and posturographic findings. 61
3385445 1988
481
Cerebellar dysfunction in patients with bronchogenic carcinoma: immunological investigations. 61
3385446 1988
482
Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes. 61
3346369 1988
483
Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. 61
3352511 1988
484
Paraneoplastic cerebellar degeneration in a patient with ovarian carcinoma. 61
3124581 1988
485
Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy. 61
2825975 1988
486
Paraneoplastic cerebellar degeneration associated with Hodgkin's disease. 61
3430191 1987
487
Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration. 61
3307712 1987
488
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. 61
3474619 1987
489
Autoimmune pathogenesis of paraneoplastic neurological syndromes. 61
3315239 1987
490
Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. 61
3528917 1986
491
Antibodies to brain proteins in paraneoplastic cerebellar degeneration. 61
3748381 1986
492
Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. 61
3004320 1986
493
Paraneoplastic cerebellar disease. Remission with excision of the primary tumor. 61
4062621 1985
494
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. 61
2416270 1985
495
Immunofluorescent labeling of nonhuman cerebellar tissue with sera from patients with systemic cancer and paraneoplastic cerebellar degeneration. 61
3931402 1985
496
[Paraneoplastic cerebellar degeneration]. 61
6471964 1984
497
[An autopsy case of carcinomatous subacute cerebellar degeneration--on distribution of cerebellar cortical lesions]. 61
6091706 1984
498
Paraneoplastic cerebellar degeneration. A clinical and CT study. 61
6597869 1984
499
Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. 61
6360029 1983

Variations for Paraneoplastic Cerebellar Degeneration

Expression for Paraneoplastic Cerebellar Degeneration

Search GEO for disease gene expression data for Paraneoplastic Cerebellar Degeneration.

Pathways for Paraneoplastic Cerebellar Degeneration

GO Terms for Paraneoplastic Cerebellar Degeneration

Sources for Paraneoplastic Cerebellar Degeneration

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....